Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07387224Active Not Recruiting

Identification of Patients With Advanced Chronic Diseases in Need of Palliative Care

Role: lead

NCT07372170Recruiting

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Role: lead

NCT07310693Recruiting

External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients

Role: lead

All 3 trials loaded